Aveanna Healthcare Holdings Inc. (AVAH) fair value analysis

Nasdaq · Updated 2026-09-07

Aveanna Healthcare Holdings Inc. is a provider of home health and hospice services in the United States. The company operates across multiple states, delivering care services to patients in their homes.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, AVAH is trading at more than a 25% discount to estimated fair value.

AVAH currently ranks #29 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $9.61
Sector: Healthcare
12-month range: $6.29–$9.61

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: High
RSI zone: Overbought
50/200-day trend: Mixed
52-week position: The top quarter of its range

What our data shows for AVAH

Our model validated 9 trailing price-to-earnings windows for AVAH, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $6.29–$9.61.
The 14-day relative strength index sits at an overbought 76.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for AVAH
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent AVAH news

TickrTrends' derived news-sentiment signal for AVAH is currently leaning positive, computed from recent coverage.

AVAH Maintained by Barclays -- Price Target Raised to $15.00 (gurufocus.com, 2026-08-28)
TickrTrends take: Barclays raised its price target for AVAH to fifteen dollars, signaling analyst confidence in the company's near-term prospects within the Healthcare sector. Given TickrTrends' current undervalued assessment, this analyst action provides external validation that the market may not be fully pricing in AVAH's value. Investors monitoring the stock should track whether this price target adjustment gains traction among other analysts covering the Healthcare company.
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue? (zacks.com, 2026-08-28)
TickrTrends take: AVAH recently reached its 52 week high, which presents a critical test for whether the stock can sustain upward momentum from its valuation perspective. Given TickrTrends' current undervalued assessment, observers should monitor whether the stock's recent strength reflects fundamental improvements in the Healthcare sector dynamics or represents a temporary move that could reverse toward fair value levels. The key consideration for valuation-focused investors is whether the price movement closes the gap between current market levels and the company's intrinsic value metrics.
Morning Market Movers: RFAI, SUGP, DFNS, USDE See Big Swings (rttnews.com, 2026-08-21)
TickrTrends take: AVAH was not mentioned in the morning market movers headline, which suggests the stock experienced relatively stable trading compared to the more volatile tickers highlighted. Given TickrTrends' current undervalued assessment, investors focused on valuation metrics should monitor whether AVAH maintains its pricing stability or shows increased trading activity that might reflect changing market sentiment toward the Healthcare sector. The absence of AVAH from significant swing activity could indicate the market has not yet fully repriced the stock relative to TickrTrends' valuation analysis.

What people are saying

Follow the AVAH conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is AVAH stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), AVAH is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is AVAH's TickrTrends verdict?

AVAH's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does AVAH compare to other Healthcare stocks?

AVAH ranks #29 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is AVAH overbought or oversold?

AVAH's 14-day RSI is in the overbought zone on TickrTrends' latest weekly data.

All Healthcare fair-value coverage →

Head-to-head comparisons

AVAH vs CI · AVAH vs GEHC · AVAH vs HSTM · AVAH vs IDXX · AVAH vs INDV